Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...
An Alzheimer's treatment, lecanemab, was found to triple the risk of death within a year, compared with dementia sufferers ...
Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...
A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in ...
As therapies for rare and neurological diseases earn accelerated approval, experts laud the program’s intent while remaining ...
After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.
GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...
New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective.
Nilotinib, a drug approved ... PhD, Alzheimer’s Association senior vice president of medical and scientific operations, said ...
Based on early, interim data, Lexeo is already positioning its gene therapy as a potentially safer alternative than available anti-amyloid drugs.
Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...
Caris said MI Cancer Seek will be used as a companion diagnostic to identify cancer patients who may benefit from treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback